AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Efficacy of Therapeutic Percutaneous Electrolysis Simple vs Multifiliar Therapy in Supraspinatus Tendinopathy.

RecruitingNAAges 18 Years - 65 YearsAllUniversidad Pontificia de Salamanca
💬

In plain words

What the trial is, and whether it could suit you

Supraspinatus tendinopathy (SE) is one of the main pathologies that cause functional alterations in the glenohumeral joint. It reduces the quality of life of the population suffering from this injury. This pathology is the most frequent cause of pain in this joint. Symptoms are aggravated by repetitive work performed at or above shoulder height and sports that involve movements above the head. Single-blind randomised clinical trial. The participants in this study will be patients selected from the ValleSur physiotherapy clinic in Ávila from January to May 2026. These patients will be diagnosed beforehand by an orthopaedic surgeon through a complete series of orthopaedic and complementary diagnostic tests. Following the clinical examination conducted by the principal investigator to verify the presence of tendinopathy in the supraspinatus and identify the selection criteria in the select

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Signing of informed consent both to participate in the study and to undergo invasive physiotherapy techniques. * Presence of symptoms (inflammation or pain) ≥ 4 weeks. * Positive palpation test of the supraspinatus tendon. * Men and women over 18 years of age. * Score of 3 or higher on the shoulder pain analogue scale. * Adequate cognitive ability for understanding. * Limited range of motion. * Rotator cuff tendinopathy confirmed by ultrasound at the study centre, either due to tendon inflammation, presence of hypoechoic areas, calcification, fibrillar disorganisation and/or neovascularisation in the supraspinatus muscle. * Pain in the proximal lateral part of the arm that worsens with abduction. Exclusion Criteria: * Any related acute or chronic musculoskeletal disease that may affect the results of the study. * Presence of neuropathic pain such as lumbar radiculopathy, which may affect the results of the study. * Not receiving the treatment sessions and assessments of the study. * History of glenohumeral fracture and rheumatoid arthritis. * Rheumatic, neurological or structural polymyalgia affecting the joint. * Pregnancy. * Patients with cardiovascular disease. * Patients with neurological disease. * Local infection. * Tumours. * Belonephobia. * Taking anticoagulants or antiplatelet agents. * Infiltrative and/or rehabilitative treatment in the two months prior to recruitment. * Treatment with another intervention during the study.
💊

What it tests

  • Electrolysis percutaneus
  • Laser
📍

Where

1 site
Universidad Pontificia de Salamanca
Salamanca, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy